bayer loses landmark indian drug case
Last Updated : GMT 06:49:16
Arab Today, arab today
Arab Today, arab today
Last Updated : GMT 06:49:16
Arab Today, arab today

Bayer loses landmark Indian drug case

Arab Today, arab today

Arab Today, arab today Bayer loses landmark Indian drug case

Mumbai - Arabstoday

Germany’s Bayer has lost a landmark drug ruling in India, forcing it to grant a compulsory licence for its cancer treatment Nexavar to Natco Pharma in a move that could bring down the cost of other pricey medicines. The Indian Patent Office issued its first ever compulsory licence to Natco, a local generic drug manufacturer, effectively ending the German drugmaker’s monopoly in India on the drug for treating kidney and liver cancer. Natco’s chief financial officer said on Monday it won the right to make the drug under a provision of the Indian Patents Act allowing a compulsory licence after three years of the grant of patent on drugs that are not available at affordable prices. Medecins Sans Frontieres (MSF), which campaigns for access to drugs in poor countries, welcomed the move, which it said would bring the price of the drug in India down from over $5,500 a month to close to $175. “This decision serves as a warning that when drug companies are price gouging and limiting availability, there is a consequence,” said Michelle Childs, director of policy at the Geneva-based charity. MSF believes the move means that new medicines in India that are still under patent, including some of the latest treatments for HIV/AIDS.

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

bayer loses landmark indian drug case bayer loses landmark indian drug case

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

bayer loses landmark indian drug case bayer loses landmark indian drug case

 



GMT 13:25 2017 Tuesday ,07 March

Received offer to join Ahly

GMT 11:36 2017 Saturday ,26 August

PT Pupuk Indonesia to produce competitive products

GMT 03:13 2017 Tuesday ,07 March

Tadweer celebrates National Environment Day

GMT 05:51 2017 Thursday ,10 August

Israeli forces shoot a Palestinian in head

GMT 09:26 2017 Tuesday ,14 February

Kuwaiti MP wants medical insurance for expats

GMT 23:05 2017 Monday ,27 February

Iraq forces reach key Mosul bridge

GMT 02:15 2017 Friday ,14 April

Football bus attacker was IS member in Iraq

GMT 17:41 2016 Thursday ,28 July

2 Gunmen Killed in Clashes in Tunisia

GMT 12:29 2017 Monday ,13 November

Lauda warns about future of F1 under new owners

GMT 02:24 2017 Saturday ,14 October

September24th-October23rd

GMT 10:29 2017 Friday ,01 September

King, Turkish president exchange Eid greetings

GMT 14:05 2017 Monday ,30 January

2 Egyptian candidates vying for AU commissioners
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday